The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
IPSC · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
MITQ · Healthcare · No moat
Doesn't clear the bar
The balanceSheet component abstained: No debt, cash, or interest-expense disclosures to score the balance sheet. The other four 20% weights were renormalized over the scored 80%.
PTGX · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | IPSC | MITQ | PTGX | VIVS |
|---|---|---|---|---|
| Moat Score (0–100) | 36 (highest) | 36 (highest) | 36 (highest) | 36 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 63 (highest) | 57 | 60 | 15 |
| Pricing power | — | 42 | — | 91 (highest) |
| Returns on capital | 0 | 0 | 4 (highest) | 0 |
| Balance-sheet safety | 55 (highest) | — | 55 (highest) | 28 |
| Capital allocation | 24 | 44 (highest) | 24 | 44 (highest) |
| No price data | No price data | No price data | No price data | |
| Market cap | $185M | $5.1M | $8.5B | $1.2M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2026 |